Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion

NCT05548270 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

503

Enrollment

INDUSTRY

Sponsor class

Conditions

Motion Sickness

Interventions

DRUG: DPI-386 Nasal Gel
DRUG: Placebo

Sponsor

Repurposed Therapeutics, Inc.